Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
5.72
-0.01 (-0.17%)
At close: Sep 4, 2025, 4:00 PM
5.53
-0.19 (-3.32%)
After-hours: Sep 4, 2025, 7:48 PM EDT
Imunon Market Cap
Imunon has a market cap or net worth of $14.42 million as of September 4, 2025. Its market cap has decreased by -12.07% in one year.
Market Cap
14.42M
Enterprise Value
10.89M
1-Year Change
-12.07%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $14.42M, a decrease of -61.75%. That is a compound annual growth rate of -3.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 12.60M | -8.70% |
Dec 31, 2024 | 13.80M | 115.63% |
Dec 29, 2023 | 6.40M | -36.00% |
Dec 30, 2022 | 10.00M | -78.59% |
Dec 31, 2021 | 46.70M | 75.56% |
Dec 31, 2020 | 26.60M | -31.62% |
Dec 31, 2019 | 38.90M | 47.35% |
Dec 31, 2018 | 26.40M | -38.60% |
Dec 29, 2017 | 43.00M | 444.30% |
Dec 30, 2016 | 7.90M | -82.29% |
Dec 31, 2015 | 44.60M | -4.09% |
Dec 31, 2014 | 46.50M | -12.10% |
Dec 31, 2013 | 52.90M | -81.56% |
Dec 31, 2012 | 286.80M | 531.72% |
Dec 30, 2011 | 45.40M | 73.95% |
Dec 31, 2010 | 26.10M | -34.09% |
Dec 31, 2009 | 39.60M | 77.58% |
Dec 31, 2008 | 22.30M | -30.75% |
Dec 31, 2007 | 32.20M | 57.07% |
Dec 29, 2006 | 20.50M | -52.87% |
Dec 30, 2005 | 43.50M | -52.51% |
Dec 31, 2004 | 91.60M | -52.76% |
Dec 31, 2003 | 193.90M | 367.23% |
Dec 31, 2002 | 41.50M | -26.29% |
Dec 31, 2001 | 56.30M | -12.58% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 660.01B |
Johnson & Johnson | 428.83B |
AbbVie | 374.37B |
UnitedHealth Group | 279.67B |
Novo Nordisk | 248.91B |
AstraZeneca | 247.16B |
Novartis AG | 244.04B |
Abbott Laboratories | 228.80B |